AP20187-mediated activation of a chimeric insulin receptor results in insulin-like actions in skeletal muscle and liver of diabetic mice

Gabriella Cotugno, Pietro Formisano, Ferdinando Giacco, Pasqualina Colella, Francesco Beguinot, Alberto Auricchio

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Diabetes mellitus (DM) derives from either insulin deficiency (type 1) or resistance (type 2). Insulin regulates glucose metabolism and homeostasis by binding to a specific membrane receptor (IR) with tyrosine kinase activity, expressed by its canonical target tissues. General or tissue-specific IR ablation in mice results in complex metabolic abnormalities, which give partial insights into the role of IR signaling in glucose homeostasis and diabetes development. We generated a chimeric IR (LFv2IRE) inducible on administration of the small molecule drug AP20187. This represents a powerful tool to induce insulin receptor signaling in the hormone target tissues in DM animal models. Here we use adeno-associated viral (AAV) vectors to transduce muscle and liver of nonobese diabetic (NOD) mice with LFv2IRE. Systemic AP20187 administration results in time-dependent LFv2IRE tyrosine phosphorylation and activation of the insulin signaling pathway in both liver and muscle of AAV-treated NOD mice. AP20187 stimulation significantly increases hepatic glycogen content and muscular glucose uptake similarly to insulin. The LFv2IRE-AP20187 system represents a useful tool for regulated and rapid tissue-specific restoration of IR signaling and for dissection of insulin signaling and function in the hormone canonical and noncanonical target tissues.

Original languageEnglish (US)
Pages (from-to)106-117
Number of pages12
JournalHuman Gene Therapy
Volume18
Issue number2
DOIs
StatePublished - Feb 2007
Externally publishedYes

Fingerprint

Insulin Receptor
Skeletal Muscle
Insulin
Liver
Inbred NOD Mouse
Glucose
Diabetes Mellitus
Homeostasis
Hormones
Muscles
Liver Glycogen
Protein-Tyrosine Kinases
Tyrosine
Dissection
Animal Models
Phosphorylation
AP20187
Membranes
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Genetics

Cite this

AP20187-mediated activation of a chimeric insulin receptor results in insulin-like actions in skeletal muscle and liver of diabetic mice. / Cotugno, Gabriella; Formisano, Pietro; Giacco, Ferdinando; Colella, Pasqualina; Beguinot, Francesco; Auricchio, Alberto.

In: Human Gene Therapy, Vol. 18, No. 2, 02.2007, p. 106-117.

Research output: Contribution to journalArticle

Cotugno, Gabriella ; Formisano, Pietro ; Giacco, Ferdinando ; Colella, Pasqualina ; Beguinot, Francesco ; Auricchio, Alberto. / AP20187-mediated activation of a chimeric insulin receptor results in insulin-like actions in skeletal muscle and liver of diabetic mice. In: Human Gene Therapy. 2007 ; Vol. 18, No. 2. pp. 106-117.
@article{bb95091b8bab42daae89f50addd2f160,
title = "AP20187-mediated activation of a chimeric insulin receptor results in insulin-like actions in skeletal muscle and liver of diabetic mice",
abstract = "Diabetes mellitus (DM) derives from either insulin deficiency (type 1) or resistance (type 2). Insulin regulates glucose metabolism and homeostasis by binding to a specific membrane receptor (IR) with tyrosine kinase activity, expressed by its canonical target tissues. General or tissue-specific IR ablation in mice results in complex metabolic abnormalities, which give partial insights into the role of IR signaling in glucose homeostasis and diabetes development. We generated a chimeric IR (LFv2IRE) inducible on administration of the small molecule drug AP20187. This represents a powerful tool to induce insulin receptor signaling in the hormone target tissues in DM animal models. Here we use adeno-associated viral (AAV) vectors to transduce muscle and liver of nonobese diabetic (NOD) mice with LFv2IRE. Systemic AP20187 administration results in time-dependent LFv2IRE tyrosine phosphorylation and activation of the insulin signaling pathway in both liver and muscle of AAV-treated NOD mice. AP20187 stimulation significantly increases hepatic glycogen content and muscular glucose uptake similarly to insulin. The LFv2IRE-AP20187 system represents a useful tool for regulated and rapid tissue-specific restoration of IR signaling and for dissection of insulin signaling and function in the hormone canonical and noncanonical target tissues.",
author = "Gabriella Cotugno and Pietro Formisano and Ferdinando Giacco and Pasqualina Colella and Francesco Beguinot and Alberto Auricchio",
year = "2007",
month = "2",
doi = "10.1089/hum.2006.116",
language = "English (US)",
volume = "18",
pages = "106--117",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - AP20187-mediated activation of a chimeric insulin receptor results in insulin-like actions in skeletal muscle and liver of diabetic mice

AU - Cotugno, Gabriella

AU - Formisano, Pietro

AU - Giacco, Ferdinando

AU - Colella, Pasqualina

AU - Beguinot, Francesco

AU - Auricchio, Alberto

PY - 2007/2

Y1 - 2007/2

N2 - Diabetes mellitus (DM) derives from either insulin deficiency (type 1) or resistance (type 2). Insulin regulates glucose metabolism and homeostasis by binding to a specific membrane receptor (IR) with tyrosine kinase activity, expressed by its canonical target tissues. General or tissue-specific IR ablation in mice results in complex metabolic abnormalities, which give partial insights into the role of IR signaling in glucose homeostasis and diabetes development. We generated a chimeric IR (LFv2IRE) inducible on administration of the small molecule drug AP20187. This represents a powerful tool to induce insulin receptor signaling in the hormone target tissues in DM animal models. Here we use adeno-associated viral (AAV) vectors to transduce muscle and liver of nonobese diabetic (NOD) mice with LFv2IRE. Systemic AP20187 administration results in time-dependent LFv2IRE tyrosine phosphorylation and activation of the insulin signaling pathway in both liver and muscle of AAV-treated NOD mice. AP20187 stimulation significantly increases hepatic glycogen content and muscular glucose uptake similarly to insulin. The LFv2IRE-AP20187 system represents a useful tool for regulated and rapid tissue-specific restoration of IR signaling and for dissection of insulin signaling and function in the hormone canonical and noncanonical target tissues.

AB - Diabetes mellitus (DM) derives from either insulin deficiency (type 1) or resistance (type 2). Insulin regulates glucose metabolism and homeostasis by binding to a specific membrane receptor (IR) with tyrosine kinase activity, expressed by its canonical target tissues. General or tissue-specific IR ablation in mice results in complex metabolic abnormalities, which give partial insights into the role of IR signaling in glucose homeostasis and diabetes development. We generated a chimeric IR (LFv2IRE) inducible on administration of the small molecule drug AP20187. This represents a powerful tool to induce insulin receptor signaling in the hormone target tissues in DM animal models. Here we use adeno-associated viral (AAV) vectors to transduce muscle and liver of nonobese diabetic (NOD) mice with LFv2IRE. Systemic AP20187 administration results in time-dependent LFv2IRE tyrosine phosphorylation and activation of the insulin signaling pathway in both liver and muscle of AAV-treated NOD mice. AP20187 stimulation significantly increases hepatic glycogen content and muscular glucose uptake similarly to insulin. The LFv2IRE-AP20187 system represents a useful tool for regulated and rapid tissue-specific restoration of IR signaling and for dissection of insulin signaling and function in the hormone canonical and noncanonical target tissues.

UR - http://www.scopus.com/inward/record.url?scp=33947433991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947433991&partnerID=8YFLogxK

U2 - 10.1089/hum.2006.116

DO - 10.1089/hum.2006.116

M3 - Article

VL - 18

SP - 106

EP - 117

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 2

ER -